Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Liver Diseases × Adjuvants, Pharmaceutic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Lung Neoplasms 1 Liver Diseases 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1

Interventions

atezolizumab 2 Bevacizumab 2 pembrolizumab 1 lenvatinib 1 camrelizumab 1 User-Centered Design 1 Neuropsychological Tests 1 Neoadjuvant Therapy 1 Liver Transplantation 1 Lead 1 Injections 1 Control Groups 1 Catheter Ablation 1 Antibodies 1 Adjuvants, Pharmaceutic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04727307 2025-09-30

AB-LATE02

University Hospital, Montpellier

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡